tiprankstipranks

Krishna Yeshwant Insider Profile

18 Followers
Krishna Yeshwant, Director at Foundation Medicine, holds 12.17M shares in Verve Therapeutics (Ticker: VERV), holds 0.00 shares in Foundation Medicine (Ticker: FMI), holds ― shares in EQRx, Inc. (Ticker: EQRX). Most recently, Krishna Yeshwant Bought ― shares of Verve Therapeutics on Dec 05, 2023 for an estimated value of 18.00M.
tipranks
Krishna Yeshwant

Krishna Yeshwant
Foundation Medicine (FMI)
Director

Ranked #91,959 out of 99,335 Corporate Insiders

Profitable Transactions

40%
2 out of 5 Profitable Transactions

Average Return

-48.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$55M
100.00%
A breakdown of Krishna Yeshwant's holdings

Insider Roles

Verve Therapeutics
(VERV)
Director, Ten Percent Owner
Roles that Krishna Yeshwant holds in companies

Most Profitable Insider Trade

Stock:
Foundation Medicine
(FMI)
Rating:Informative Sell
Date:May 18, 2015 - May 18, 2016
Return:+52.20%
The most profitable trade made by Krishna Yeshwant

Krishna Yeshwant's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
FMI
Foundation Medicine
Aug 02, 2018
Uninformative Sell
792.68K
$0.00
Verve Therapeutics
Dec 05, 2023
Director, Ten Percent Owner
Informative Buy
18.00M
$55.37M
EQRX
EQRx, Inc.
List of latest transactions for each holding click on a transaction to see Krishna Yeshwant's performance on stock

Krishna Yeshwant insider profile FAQ

What is the percentage of profitable transactions made by Krishna Yeshwant?
The percentage of profitable transactions made by Krishna Yeshwant is 40%.
    What is the average return per transaction made by Krishna Yeshwant?
    The average return per transaction made by Krishna Yeshwant is -48.10%.
      What stocks does Krishna Yeshwant hold?
      Krishna Yeshwant holds: FMI, VERV, EQRX stocks.
        What was Krishna Yeshwant’s latest transaction?
        Krishna Yeshwant latest transaction was an Informative Buy of $18.00M.
          What was Krishna Yeshwant's most profitable transaction?
          Krishna Yeshwant’s most profitable transaction was an Informative Sell of FMI stock on May 18, 2015. The return on the trade was 52.20%.
            What is Krishna Yeshwant's role in Foundation Medicine?
            Krishna Yeshwant's role in Foundation Medicine is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.